truth banner

 Most hospice industry pharmacy benefit managers (PBM's) and mail-order vendors are in the process of either merging, selling, or repackaging their products in an attempt to provide the type of service model that Delta Care Rx has offered from the beginning.

They can copy our words and phrases, distribute propaganda, and do all they can to ignore the profound change that our Rx billing model has brought to the industry - but there still only remains just ONE definition of TRULY TRANSPARENT & PASS-THROUGH Rx PURCHASING.


ALL THE PROOF YOU NEED CAN BE FOUND IN A SIMPLE APPLES-TO-APPLES COST COMPARISON 

 -

elephant DELTA CARE Rx PIONEERED THE TERM TRANSPARENCY AS IT APPLIES TO THE HOSPICE PHARMACY SOLUTIONS INDUSTRY. Since then, our competitors have scrambled to suggest that they "will soon offer the same unique billing model" that Delta has offered from the beginning.

UNFORTUNATELY FOR THEM, even the most convincing magic, smoke, mirrors, or "hybrid" solutions cannot distort the reality of what will always be just ONE accurate definition of TRULY transparent and pass-through Rx purchasing. We are most grateful to our valued clients, who have helped us pioneer such positive change in the hospice PBM sector.
SO WHAT IS THE SECRET BEHIND THE TRICK that allows Delta clients to experience such incredibly low per patient day drug costs, along with the purchasing flexibility necessary to manage and afford ALL of the CMS chaos experienced in 2014 and 2015?


THE SECRET IS...THERE IS NO TRICK. Delta provides a truly transparent and pass-through Rx billing model, called HO$PICE TAPER." Transparency is powerful, but very limited if not coupled with a "fully auditable" Rx purchasing contract that ensures the complete pass-through of ALL acquisition costs, rebates, and/or network discounts that the provider has access to.

REAL PASS-THROUGH CONTRACTS SHOULD ALWAYS READ: "What the hospice pays for medication is 100% EQUAL to what the dispensing pharmacist is reimbursed for filling the order." Most hospice PBM agreements (not Delta) charge the hospice one amount, while then reimbursing the dispensing pharmacist a vastly different and much lesser amount. PBM provider profits are found in the difference that remains. This is known as the "PBM spread." Nearly all of the evolving competitor business models still contain some form of PBM spread; either purposely, or via a third-party processing relationship that they utilize.

CONTINUING TO PURCHASE MEDICATIONS via non-transparent and non pass-through Average Wholesale Price (AWP) discounts, OR overpriced and very restrictive per diem arrangements is NOT financially sustainable for any size hospice in light of exponential CMS driven change.